AIV
60
3
BAX
41
3
DHR
50
4
ADBE
66
4
MU
43
-4
UAL
34
-3
MCD
46
4
AAPL
56
-3
ABBV
68
-3
ICE
67
3
NWL
32
4
DAL
48
-2
EFX
55
-2
EQT
19
-5
VZ
25
-2
SHW
61
2
BSX
70
2
HRL
29
2
RL
76
-3
SLG
71
-4
AIV
60
3
BAX
41
3
DHR
50
4
ADBE
66
4
MU
43
-4
UAL
34
-3
MCD
46
4
AAPL
56
-3
ABBV
68
-3
ICE
67
3
NWL
32
4
DAL
48
-2
EFX
55
-2
EQT
19
-5
VZ
25
-2
SHW
61
2
BSX
70
2
HRL
29
2
RL
76
-3
SLG
71
-4
Financhill
Back

Cabaletta Bio Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Sell
26

CABA
Cabaletta Bio

Last Price:
8.48
Seasonality Move:
32.25%
Sell
43

RARE
Ultragenyx Pharmaceutical

Last Price:
39.58
Seasonality Move:
3.65%
Sell
26
Cabaletta Bio (CABA) is a Sell

Is Cabaletta Bio a Buy, Sell or Hold?

  • The current Cabaletta Bio [CABA] share price is $8.45. The Score for CABA is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
  • CABA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $39.60. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CABA Stock Price Chart

What is Cabaletta Bio's stock price today?

  • The Cabaletta Bio share price today is $8.45
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CABA is experiencing slight selling pressure.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $39.60
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing buying pressure, which is a positive indicator for future bullish movement.

CABA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.86 Sell
Relative Strength Index (14 RSI): 33.78 Sell
Chaikin Money Flow: -645391 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (9.5 - 12.06) Sell
Bollinger Bands (100): (11.31 - 21.31) Sell

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.73 Sell
Relative Strength Index (14 RSI): 45.77 Sell
Chaikin Money Flow: 722527 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.99 - 42.29) Sell
Bollinger Bands (100): (41.03 - 48.83) Sell

CABA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 10.12 Sell
20-day SMA: 10.38 Sell
50-day SMA: 11.94 Sell
200-day SMA: 16.91 Sell
8-day EMA: 9.54 Sell
20-day EMA: 10.42 Sell
50-day EMA: 12.26 Sell
200-day EMA: 15.07 Sell

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 40.38 Sell
20-day SMA: 40.41 Sell
50-day SMA: 41.94 Sell
200-day SMA: 42.46 Sell
8-day EMA: 39.76 Sell
20-day EMA: 40.54 Sell
50-day EMA: 42.03 Sell
200-day EMA: 43.46 Sell

Cabaletta Bio Earnings Growth & CABA Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.06 per share, a decrease this year of $0.55 per share, and an increase next year of $0.04 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.

Cabaletta Bio Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):